Eli Lilly CEO Dave Ricks on revolutionizing healthcare and medicine

The increasing popularity of GLP-1 weight-loss drugs has driven drugmaker Eli Lilly to become the largest pharmaceutical company in the world by market capitalization. Eli Lilly Chair and CEO Dave Ricks joined Goldman Sachs' John Waldron for a Goldman Sachs Talks session to discuss Lilly's journey with medicine for chronic weight management, his view on how medicine is changing and the new problems it's attempting to solve, and how he leads an organization where innovation is a necessity. Record Date – March 12, 2024 0:00 Introduction 1:01 Career journey 2:43 Industry lessons 4:50 Competitive advantages 8:23 Sustaining innovation 10:32 GLP-1 progress 13:54 Medical advancements 15:55 Alzheimer's progress 16: 45 Medicine industry 17:48 Supply constraints 20:23 Gene therapy 22: 34 AI usage 25:19 Intellectual property protections 27:43 Sustained success 30:03 Conclusion